Chemours reported net sales of $1.2 billion and net income of $76 million for the third quarter of 2020. The company's adjusted EBITDA was $210 million, and it generated a free cash flow of $252 million. The results reflect the company's resilience and execution in a challenging environment.
Net Sales of $1.2 billion.
Net Income of $76 million, with EPS of $0.46.
Adjusted Net Income of $78 million, with Adjusted EPS of $0.47.
Free Cash Flow of $252 million, a $92 million improvement from prior year.
Chemours is confident in creating sustained value through the economic recovery and remains committed to achieving its full potential.
Analyze how earnings announcements historically affect stock price performance